戻る
Galmed Pharmaceuticals Ltd (GLMD)価格
GLMD 株価推移チャート
GLMD 収入
Galmed Pharmaceuticals Ltd
$0.77
-1.58%
$-0.01
終値： Jan 16, 16:00:00 GMT-5
$0.77
0%
$0
プレマーケット： Jan 20, 04:25:58 GMT-5
主要データ
前終値
$0.7835
始値
$0.76
当日レンジ
$0.76 - $0.7965
52週レンジ
$0.731 - $3.5
取引高
80.0K
平均取引高
2.0M
1株当たり利益(TTM)
-3.60
配当利回り
--
時価総額
$5.5M
GLMDとは何ですか？
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). The firm is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The firm's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The firm's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.